Andrew Navia

Former Postdoctoral Fellow

Degrees & Affiliations

BS, Chemistry - Emory University PhD Candidate, Chemistry - MIT

Background & Interests

Biography

Andrew is a Chemistry PhD candidate in the Shalek Lab. He is interested developing novel RNA-seq technologies and studying resistance mechanisms in cancer. He captains the lab volleyball team, Seq-and-Destroy, and plays ice hockey in his free time.

As a chemistry major at Emory University, Andrew worked in Professor Dennis Liotta’s lab synthesizing nucleotide reverse transcriptase inhibitors.

Publications

Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease

Winter et al.,
Biorxiv,
2024

Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2

Long et al.,
biorxiv,
2024

An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection

Ziegler et al.,
American Society for Microbiology,
2024

A knockoff calibration method to avoid over-clustering in single-cell RNA-sequencing

DenAdel et al.,
bioRxiv,
2024

Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data

Nwizu et al.,
bioRxiv,
2024

Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data

Nwizu et al.,
bioRxiv,
2024

Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity

Williams et al.,
Cancer Research,
2023

Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer

Raghavan et al.,
Cell,
2021

Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip

Bein et al.,
Frontiers in Pharmacology,
2021

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

Prakadan et al.,
Nature Communications,
2021